Thursday, July 11, 20244:00 PM - 5:00 PM PP01 Presentation Time: 4:00 PM Investigating Shielding as a Dose-Shaping Tool in Flattening Distal Dose Profiles for Single-Channel Vaginal Cylinders
Tien C, Mullane S, Draeger E, Rivard M, Chen Z. Thursday, July 11, 20244:00 PM - 5:00 PM PP01 Presentation Time: 4:00 PM Investigating Shielding as a Dose-Shaping Tool in Flattening Distal Dose Profiles for Single-Channel Vaginal Cylinders. Brachytherapy 2024, 23: s26-s27. DOI: 10.1016/j.brachy.2024.08.020.Peer-Reviewed Original ResearchModel-based dose calculation algorithmsSingle-channel vaginal cylinderDose profilesDose distributionVaginal cylinderCentral axisCustomized shieldingRegions of high doseAnisotropic dose distributionUniform dose profileDose calculation algorithmWater-equivalent materialDose calculation methodMonte CarloIr-192 seedsDose gridIr-192MC simulationsRelative doseShielding materialsCalculation algorithmSource transitionDose optimizationLateral radiusShieldingSaturday, July 13, 202411:30 AM - 12:30 PMGSOR01 Presentation Time: 11:30 AM A Prospective Clinical Trial Assessing Comfort of Brachytherapy with a Novel Tapered Vaginal Applicator
Mahal A, Yu J, Mahal R, Tien C, Adefres B, Damast S. Saturday, July 13, 202411:30 AM - 12:30 PMGSOR01 Presentation Time: 11:30 AM A Prospective Clinical Trial Assessing Comfort of Brachytherapy with a Novel Tapered Vaginal Applicator. Brachytherapy 2024, 23: s72-s73. DOI: 10.1016/j.brachy.2024.08.099.Peer-Reviewed Original ResearchVisual-analogue-scaleVaginal brachytherapyVaginal stretchingVaginal applicationEndometrial cancerAssociated with less painIr-192 seedsDose fall-offClinically significant responseProspective clinical trialPatient-centered evaluationVaginal introitusProspective trialsDose distributionSurface doseVaginal mucosaIr-192Less painNarrow introitusPaired t-testEC patientsConsenting patientsClinical trialsIntroitusPatientsPO0116 Design and Characterization of a Brachytherapy Applicator with Modulated Shielding (MOSH) for the Treatment of Cervical Cancer
Schwipper C, Mullane S, Draeger E, Chen Z, Rivard M, Tien C. PO0116 Design and Characterization of a Brachytherapy Applicator with Modulated Shielding (MOSH) for the Treatment of Cervical Cancer. Brachytherapy 2024, 23: s92. DOI: 10.1016/j.brachy.2024.08.134.Peer-Reviewed Original ResearchDose distributionBrachytherapy applicationsOAR dosesIr-192TG-43 dose calculation formalismShield geometryReduces dose to OARAAPM TG-43 formalismShielding materialsDose calculation formalismHigh-Z shieldingReduced OAR dosesCalculated dose distributionsTG-43 formalismDose-volume objectivesDose to OARsTreatment of cervical cancerHDR brachytherapy applicatorsHigh-risk clinical target volumeIr-192 sourceImproved dose distributionClinical target volumeSparing OARsTOPAS MCYb-169